Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
Have you ever blamed yourself when a certain diet or treatment that worked for other people didn't work for you? Or have you been upset with yourself if you regained weight you worked so hard to lose?
Weight regain can be normal.
Weight regain is driven by a biological response to weight loss, a slowing of metabolism, and an increase of hunger signals to the brain.6
Individual results vary. Risks and benefits of each treatment should be discussed with a doctor.
You may want to talk to your family doctor about your healthcare goals or seek an obesity specialist.
Your healthcare team can help coordinate care with other healthcaren professionals to begin your treatment, and provide guidance throughout your weight loss journey.
Remember that there is no one-size-fits-all approach to obesity treatment, and what works best for one person may not work for another.
The key is to have a comprehensive evaluation and collaborate with your obesity specialist to
create a personalized treatment plan that maximizes your chances of success while taking into account your body, life, and goals.
The first meeting with an obesity specialist is an important step, where you will be evaluated and assessed to determine the treatment type best suited to you. Some obesity doctors specialize in medication therapy, some in surgery, while others offer both surgery and medication therapy.
It's important to approach this initial meeting as an opportunity to gather information, ask questions, and assess the recommended treatment type.
It's important to note that aftercare programs can vary depending on the type of obesity treatment.
The goal of patient aftercare programs is to provide comprehensive support and guidance to help patients achieve and maintain their weight loss and overall health goals in the safest and most effective way possible.
Patients should actively participate in their aftercare program and maintain open communication with their healthcare providers to ensure the ability to discuss any challenges.
Nordmo MN, Danielsen YS, Nordmo MS. The challenge of keeping it off, a descriptive systematic review of high quality, follow-up studies of obesity treatments. Obesity Management. 2018. DOI:10.1111/0br.12949
Rubino D, Abrahamsson N, Davies M, et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA. 2021;325(14):1414-1425. doi: 10.1001/jama.2021.3224 2021.3224
Wilding JPH, Batterham RL, Davies M, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide. The STEP 1 trial extension. 2022.Diabetes, Obesity, and Metabolism. https://doi.org/10.1111/dom.14725
Eli Lilly and Company. Tirzepatide Demonstrated Significant and Superior Weight Loss Compared to Placebo in Two Pivotal Studies. 27/07/2023. 4) van Rijswijk AS, van Olst N, Schats W, van der Peet DL, van de Laar AW. What Is Weight Loss After Bariatric Surgery Expressed in Percentage Total Weight Loss (%TWL)? A Systematic Review. Obes Surg. 2021 Aug;31(8):3833-3847. doi: 10.1007/s11695-021-05394-x. Epub 2021 May 17. PMID: 34002289.
van Rijswijk A-S, van Olst N, Schats W, van der Peet DL, van de Laar AW. What Is Weight Loss After Bariatric Surgery Expressed in Percentage Total Weight Loss (%TWL)? A Systematic Review. Obes Surg. 2021;31(8):3833-3847. doi:10.1007/s11695-021-05394-x
Rubino F, Puhl RM, Cummings DE, et al. Joint international consensus statement for ending stigma of obesity. Nat Med. 2020;26(4):485-497. doi:10.1038/s41591-020-0803-x